What is NDC 70771-1086?

70771-1086 is the product NDC for oxybutynin, Oxybutynin chloride 5 mg/1 tablet, film coated, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 6 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for oxybutynin?

9 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

oxybutynin NDC 70771-1086 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1086Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1086Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1086-1	7077110860170771108601	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-1)Marketed from Aug 10, 2017
70771-1086-3	7077110860370771108603	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-3)Marketed from Aug 10, 2017
70771-1086-4	7077110860470771108604	10 BLISTER PACK in 1 CARTON (70771-1086-4) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (70771-1086-2)Marketed from Aug 10, 2017
70771-1086-5	7077110860570771108605	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-5)Marketed from Aug 10, 2017
70771-1086-6	7077110860670771108606	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-6)Marketed from Aug 10, 2017
70771-1086-9	7077110860970771108609	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1086-9)Marketed from Aug 10, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): oxybutynin
Generic name (nonproprietary): oxybutynin
Active ingredients: Oxybutynin chloride — 5 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202332
Marketing start: Aug 10, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 70771-1086_e2d9aa83-078e-4c67-a9d0-8c166bc4d9f0SPL ID e2d9aa83-078e-4c67-a9d0-8c166bc4d9f0SPL set ID f405a774-bd91-4513-b7c7-c44f0596d988RxCUI 863619, 863628, 863636UNII L9F3D9RENQUPC 0368382256010
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771108601 followed by a unit qualifier and the quantity

Package 70771-1086-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 3, 2024.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1086

What is NDC 70771-1086?: 70771-1086 is the product NDC for oxybutynin, Oxybutynin chloride 5 mg/1 tablet, film coated, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 6 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: oxybutynin.
What is the active ingredient?: Oxybutynin chloride.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for oxybutynin?: 9 other product NDCs are listed under this name. See all oxybutynin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other oxybutynin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
oxybutynin	Oxybutynin chloride 5 mg/1	Tablet, Film coated, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8219	00615-8219-39
oxybutynin	Oxybutynin chloride 10 mg/1	Tablet, Film coated, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8220	00615-8220-39
oxybutynin	Oxybutynin chloride 10 mg/1	Tablet, Film coated, Extended releaseOral	A-S Medication Solutions	50090-5353	50090-5353-00
oxybutynin	Oxybutynin chloride 5 mg/1	Tablet, Film coated, Extended releaseOral	Redpharm Drug	67296-2335	67296-2335-03
oxybutynin	Oxybutynin chloride 5 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-255	68382-0255-0168382-0255-0568382-0255-06+3 more
oxybutynin	Oxybutynin chloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-256	68382-0256-0168382-0256-0568382-0256-06+3 more
oxybutynin	Oxybutynin chloride 15 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-257	68382-0257-0168382-0257-0568382-0257-06+3 more
oxybutynin	Oxybutynin chloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Lifesciences Limited	70771-1087	70771-1087-0170771-1087-0370771-1087-04+3 more
oxybutynin	Oxybutynin chloride 15 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Lifesciences Limited	70771-1088	70771-1088-0170771-1088-0370771-1088-04+3 more

Other NDCs under ANDA 202332

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202332
Product	Strength	Form · route	Labeler	Product NDC
oxybutynin	Oxybutynin chloride 5 mg/1	Tablet, Film coated, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8219
oxybutynin	Oxybutynin chloride 10 mg/1	Tablet, Film coated, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8220
oxybutynin	Oxybutynin chloride 10 mg/1	Tablet, Film coated, Extended releaseOral	A-S Medication Solutions	50090-5353
oxybutynin	Oxybutynin chloride 5 mg/1	Tablet, Film coated, Extended releaseOral	Redpharm Drug	67296-2335
oxybutynin	Oxybutynin chloride 5 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-255
oxybutynin	Oxybutynin chloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-256
oxybutynin	Oxybutynin chloride 15 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	68382-257
oxybutynin	Oxybutynin chloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Lifesciences Limited	70771-1087
oxybutynin	Oxybutynin chloride 15 mg/1	Tablet, Film coated, Extended releaseOral	Zydus Lifesciences Limited	70771-1088